Browse

Increased fear of progression in cancer patients with recurrence

DC Field Value Language
dc.contributor.authorShim, Eun-Jung-
dc.contributor.authorShin, Yong-Wook-
dc.contributor.authorOh, Do-Youn-
dc.contributor.authorHahm, Bong-Jin-
dc.date.accessioned2012-05-29T02:23:12Z-
dc.date.available2012-05-29T02:23:12Z-
dc.date.issued2010-04-
dc.identifier.citationGENERAL HOSPITAL PSYCHIATRY; Vol.32 2; 169-175ko_KR
dc.identifier.issn0163-8343-
dc.identifier.urihttp://hdl.handle.net/10371/76522-
dc.description.abstractObjective: This study investigated the fear of progression (FoP) in cancer patients and the discriminant ability of the Fear of Progression Questionnaire (FoP-Q) against the Hospital Anxiety and Depression Scale (HADS), while also examining relationships between FoP, satisfaction outcomes and supportive needs. Method: The FoP-Q and HADS were administered to 112 cancer patients in Korea during June and July 2006. The FoP-Q totals and subscales, and the HADS scores were compared across three groups (patients with recurrence, patients with metastases and controls experiencing neither). Results: Comparison of the FoP-Q total score to HADS anxiety (HADS-A) and depression (HADS-D) scores showed higher FoP in the recurrence group compared to the control group (P=.009). Subscale score comparisons revealed a heightened "affective reaction" (P=.003) to cancer progression and fear of "loss of autonomy" (P=.011) in recurrence patients. FoP-Q score showed a moderate association with HADS-A (r=.54, P=.000) and a significant association with treatment satisfaction (r=.26, P=.007), medical staff and communication (r=.31, P=.001), and supportive needs (r=-.41, P=.000). Conclusion: The importance of providing supportive interventions tailored to the specific emotional concerns of cancer patients, assessed via appropriate, disease-specific instruments, and the need to pay special attention to the concerns of recurrence patients are suggested. (C) 2010 Elsevier Inc. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE INCko_KR
dc.subjectCancerko_KR
dc.subjectAnxietyko_KR
dc.subjectRecurrenceko_KR
dc.subjectSupportive needko_KR
dc.subjectTreatment satisfactionko_KR
dc.subjectFear of progressionko_KR
dc.titleIncreased fear of progression in cancer patients with recurrenceko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor심은정-
dc.contributor.AlternativeAuthor신용욱-
dc.contributor.AlternativeAuthor오도윤-
dc.contributor.AlternativeAuthor함봉진-
dc.identifier.doi10.1016/j.genhosppsych.2009.11.017-
dc.citation.journaltitleGENERAL HOSPITAL PSYCHIATRY-
dc.description.citedreferenceMehnert A, 2009, PSYCHO-ONCOLOGY, V18, P1273, DOI 10.1002/pon.1481-
dc.description.citedreferenceHERSCHBACH P, 2009, SUPPORT CARE CA 1029-
dc.description.citedreferenceHirai K, 2008, PSYCHO-ONCOL, V17, P1172, DOI 10.1002/pon.1348-
dc.description.citedreferencevan den Beuken-van Everdingen MHJ, 2008, PSYCHO-ONCOLOGY, V17, P1137, DOI 10.1002/pon.1340-
dc.description.citedreferenceHuang CH, 2008, J MED ETHICS, V34, P336, DOI 10.1136/jme.2007.020735-
dc.description.citedreferenceHart SL, 2008, SUPPORT CARE CANCER, V16, P161, DOI 10.1007/s00520-007-0296-x-
dc.description.citedreferenceROWLAND J, 2006, SURVIVORSHIP RES PRE-
dc.description.citedreferenceHerschbach P, 2005, J PSYCHOSOM RES, V58, P505, DOI 10.1016/j.jpsychores.2005.02.007-
dc.description.citedreferenceOLSSON I, 2005, BMC PSYCHIATRY, V5, P46-
dc.description.citedreferencePELTOSAARI L, 2005, DANCING FEAR-
dc.description.citedreferenceHerschbach P, 2004, BRIT J CANCER, V91, P504, DOI 10.1038/sj.bjc.6601986-
dc.description.citedreferenceKissane DW, 2004, AUST NZ J PSYCHIAT, V38, P320-
dc.description.citedreferenceMorita T, 2004, J PAIN SYMPTOM MANAG, V27, P44, DOI 10.1016/j.jpainsymman.2003.05.001-
dc.description.citedreferenceSIMS ACP, 2003, SYMPTOMS MIND INTRO-
dc.description.citedreferenceStark D, 2002, J CLIN ONCOL, V20, P3137, DOI 10.1200/JCO.2002.08.549-
dc.description.citedreferencevon Essen L, 2002, EUR J CANCER CARE, V11, P91-
dc.description.citedreferenceBjelland I, 2002, J PSYCHOSOM RES, V52, P69-
dc.description.citedreferenceSTEWART DE, 2001, MEDSCAPE WOMENS HLTH, V6, P5-
dc.description.citedreferenceGroenvold M, 1999, J CLIN EPIDEMIOL, V52, P523-
dc.description.citedreferenceOH SM, 1999, J KOREAN NEUROPSYCHI, V38, P289-
dc.description.citedreferenceHall A, 1999, EUR J CANCER, V35, P79-
dc.description.citedreferenceCameron LD, 1998, HEALTH PSYCHOL, V17, P459-
dc.description.citedreferenceGreenberg DB, 1997, CANCER, V80, P1936-
dc.description.citedreferenceSTEPTOE A, 1991, SOC SCI MED, V32, P627-
dc.description.citedreferenceRAZAVI D, 1990, BRIT J PSYCHIAT, V156, P79-
dc.description.citedreferenceZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361-
dc.description.citedreferenceKOOCHER GP, 1981, DAMOCLES SYNDROME PS-
dc.description.tc1-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse